Clinical Trial

CM336-SOC for Dynamically High-Risk Multiple Myeloma Study

Name: CM336-SOC for Dynamically High-Risk Multiple Myeloma Study — clinical trial record (NCT07648459)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: CAREMM-013

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is a single-arm, open-label study to evaluate the efficacy and safety of CM336 combined with SOC therapy in patients with dynamically high-risk multiple myeloma.

Trial Details

NCT Number	NCT07648459
Lead Sponsor	Institute of Hematology & Blood Diseases Hospital, China
Conditions	Multiple Myeloma
Enrollment	46 participants
Start Date	2026-06-01
Primary Completion	2027-07-09 (estimated)
Study Completion	2028-07-30 (estimated)
Updated on ClinicalTrials.gov	2026-06-15